Every‐other‐day Palonosetron Plus Aprepitant for Prevention of Emesis Following Induction Chemotherapy for Acute Myeloid Leukemia: A Randomized, Controlled Study From the “Rete Ematologica Pugliese”

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2628
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2013English

Aprepitant Versus Dexamethasone for Delayed Emesis: What Is the Role of the 5-Hydroxytryptamine Type 3 Receptor Antagonist Palonosetron?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Micafungin Prophylaxis for Acute Leukemia Patients Undergoing Induction Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2018English

Crude Coal Tar Treatment Every Day Versus Every Other Day for Plaque Psoriasis

Acta Dermato-Venereologica
DermatologyMedicine
2001English

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

Clinical Hematology International
2019English

Efficacy of the Combination Use of Aprepitant and Palonosetron for Improving Nausea in Various Moderately Emetogenic Chemotherapy Regimens

BMC pharmacology & toxicology
MedicinePharmacology
2019English

The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia

2020English

Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Bone Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy